Clinical Medicine Reviews in Oncology

Aims and Scope

Clinical Medicine Reviews in Oncology is an international, peer reviewed journal that focuses primarily on cancer therapeutics.  The journal specializes in focused reviews of individual drug therapies, combination therapies and classes of drugs.  The journal also considers papers addressing the prevention, diagnosis and management of disorders associated with this area.

This Clinical Medicine Reviews journal offers efficient publishing, high editorial quality and no article processing fees or other fees for authors.  It is not an open access journal.  Authors will be asked to assign copyright in their article to the publisher, and will not be permitted to distribute or archive the published version of the paper without the publisher’s consent for a period of twelve months after the date of publication.  This does not affect authors' right to deposit the accepted version of the manuscript in a pre-print archive.  To avoid possible misunderstandings authors are asked to confirm their understanding of this following manuscript submission.

Standard Author Services

The journal distinguishes itself from others in the field by combining individualized author service with editorial integrity and procedural efficiency.  At every stage authors will be introduced to the staff member responsible for their paper and will receive procedural explanations and regular status updates.  The progress of authors’ papers is continually monitored by staff, and a staff member is always available to answer authors' questions.  This is reflected in our consistently positive author testimonials. 

• Submission to first editorial decision including rigorous, expert peer review in average four weeks

• Rapid publication in two to four weeks after acceptance

• No deadlines for corrections to typeset proofs

• Paper announcement after publication through scholarly databases, social media, and opted-in newsletters

• Article level usage metrics (in beta)

• Proactive, professional journal staff

Optional Author Services

• Discounted article reprints

• English proof reading

• Pre-submission paper-matching and editor in chief consultation

• Pre-peer review language polishing and paper formatting

• Video abstracts

• Ebook on enhancing article visibility

• Social media promotion

Subscriptions and Pay-per-View

Pay to view an individual article for US$59.  To purchase an article click its Pay-per-view link.  Purchasers experiencing difficulty downloading an article should contact the publisher immediately.  Annual subscriptions are available for individual users at US$ 195 including the full back file.  Subscriptions for organizations based on defined IP addresses are available at US$ 395 including the full back file.  Order a subscription

Embargo period

Authors of papers published in this journal may not share, distribute, or deposit in an archive the final, paginated version of the article for a period of 12 months after the date of publication.  This restriction does not affect authors’ rights to deposit the final accepted version of their manuscript in an archive.

Former Open Access Option

In the past the journal has offered authors optional open access for published articles.  This option is no longer available.  If you require open access please refer to the journals homepage to find an open access journal.  All journals published by Libertas Academica are open access except the Clinical Medicine Reviews series of titles.

Manuscript Types and Preparation Guidelines

Information on manuscript types accepted for peer review and guidelines for manuscript preparation are available here.  A manuscript template, sample manuscript, and pre-submission check list are available here.

Editorial Policies

All articles are subject to blind independent peer review by reviewers drawn from the journal's editorial board, volunteer peer reviewer pool, and where necessary from Pubmed.  Pubmed is used where specialized expertise is unavailable from the other sources.  Two to four peer reviewers will be used.  Editorial decisions are made by independent editors in chief or associate editors. The editorial process from peer review to first editorial decision takes three to four weeks following acceptance of each paper for peer review.

We maintain a strict distinction between editorial decisions, made by editors in chief or associate editors, and business decisions.  Libertas does not make nor attempt to influence editorial decisions.  Editorial decision makers receive no incentives to make decisions leading to fee payments.

The journal is committed to high standards of integrity.  Authors are required to confirm their compliance with ethical and legal requirements upon submission.  Prior to publication all authors must provide signed confirmation of compliance. Where concerns arise the journal will apply the Committee on Publication Ethics guidelines on ethical matters.

Inquiries 

Correspondence should be sent to .  Contact details for Libertas staff are available here.

Frequency of Publication

Articles are published upon completion of production.

Citing Articles

Article citations follow this format:

Authors: Title.  Journal [year]:[volume] [first page]-[last page]

Additional Information for Authors

• Manuscript preparation and submission requirements

• Monitoring the status of papers under review

• More information on standard and optional services for authors